| Eger Health Care And Rehabilitation Center | |
| 140 Meisner Avenue, Staten Island, New York 10306 | |
| (718) 979-1800 | |
| Name | Eger Health Care And Rehabilitation Center |
|---|---|
| Location | 140 Meisner Avenue, Staten Island, New York |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 378 |
| Occupancy Rate | 75.03% |
| Medicare ID (CCN) | 335332 |
| Legal Business Name | Eger Health Care And Rehabilitation Center |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1356331565 |
| Organization Name | EGER HEALTH CARE AND REHABILITATION CENTER |
| Address | 140 Meisner Ave, Staten Island, NY 10306 |
| Phone Number | 718-989-3021 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
Tired of waiting for federal action to reduce prescription drug costs, Colorado is acting on its own — even if it must do so with one arm tied behind its back.
Below are highlights of orthopaedic research studies appearing in the April 18th issue of the Journal of Bone and Joint Surgery (JBJS), as well as the issue's full Table of Contents.
In the battle against HIV/AIDS conditions on the frontlines are constantly in flux as treatment, research and policy evolve. The landmark HIV Prevention Trials Network (HPTN) 052 study, which established that antiretroviral treatment in people who are HIV positive decreases the likelihood of transmitting HIV to their sexual partners, was no exception.
Virginia Tech entomologists have developed a chromosome map for about half of the genome of the mosquito Aedes agypti, the major carrier of dengue fever and yellow fever.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
Tired of waiting for federal action to reduce prescription drug costs, Colorado is acting on its own — even if it must do so with one arm tied behind its back.
Below are highlights of orthopaedic research studies appearing in the April 18th issue of the Journal of Bone and Joint Surgery (JBJS), as well as the issue's full Table of Contents.
In the battle against HIV/AIDS conditions on the frontlines are constantly in flux as treatment, research and policy evolve. The landmark HIV Prevention Trials Network (HPTN) 052 study, which established that antiretroviral treatment in people who are HIV positive decreases the likelihood of transmitting HIV to their sexual partners, was no exception.
Virginia Tech entomologists have developed a chromosome map for about half of the genome of the mosquito Aedes agypti, the major carrier of dengue fever and yellow fever.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.53 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.01 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 59.94 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.17 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.84 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.09 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.88 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.6 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.91 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 70.69 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.08 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 29.09 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 33.04 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.8 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.93 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 69.9 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.8 | 82.93 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
Tired of waiting for federal action to reduce prescription drug costs, Colorado is acting on its own — even if it must do so with one arm tied behind its back.
Below are highlights of orthopaedic research studies appearing in the April 18th issue of the Journal of Bone and Joint Surgery (JBJS), as well as the issue's full Table of Contents.
In the battle against HIV/AIDS conditions on the frontlines are constantly in flux as treatment, research and policy evolve. The landmark HIV Prevention Trials Network (HPTN) 052 study, which established that antiretroviral treatment in people who are HIV positive decreases the likelihood of transmitting HIV to their sexual partners, was no exception.
Virginia Tech entomologists have developed a chromosome map for about half of the genome of the mosquito Aedes agypti, the major carrier of dengue fever and yellow fever.
› Verified 1 days ago
Sea View Hospital Rehabilitation Center And Home Location: 460 Brielle Ave, Staten Island, New York 10314 Phone: (718) 317-3000 | |
Silver Lake Specialized Rehab And Care Center Location: 275 Castleton Avenue, Staten Island, New York 10301 Phone: (718) 447-7800 | |
Clove Lakes Health Care And Rehab Center, Inc Location: 25 Fanning Street, Staten Island, New York 10314 Phone: (718) 289-7900 | |
Verrazano Nursing Home Location: 100 Castleton Avenue, Staten Island, New York 10301 Phone: (718) 273-1300 | |
Eger Health Care And Rehabilitation Center Location: 140 Meisner Avenue, Staten Island, New York 10306 Phone: (718) 979-1800 | |
New Vanderbilt Rehabilitation And Care Center, Inc Location: 135 Vanderbilt Ave, Staten Island, New York 10304 Phone: (718) 447-0701 |